Advertisement Nutraceutical sees rise in Q4 sales - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nutraceutical sees rise in Q4 sales

Nutraceutical, a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores, has reported net sales of $42.81m for the fourth quarter ended 30 September 2010, compared to $41.35m for the comparable period in 2009.

Nutraceutical posted a net income of $3.54m for the fourth quarter 2010, or $0.34 per diluted share, compared to net income of $3.19m, or $0.29 per diluted share, for the comparable period in 2009.

For the full year ended 30 September 2010, the company has posted revenue of $180.05m, compared to $162.35m for the year ago period.

Nutraceutical has generated a net income of $16.38, or $1.56 per diluted sharefor the full year period, compared to net loss of $14.04m, or $1.29 loss per diluted share, for the year ago period.

Nutraceutical chairman and CEO Bill Gay said that their fiscal 2010 net sales, net income and Adjusted EBITDA were all strong.

"This was a direct result of being able to integrate a number of favorable acquisitions into our business structure in a short period of time," Gay.

"Under the current circumstances, we will be diligent in all aspects of our business to make sure we maintain our financial strength and do what is essential for the continued long-term improvement of the company.

"In addition to new acquisitions, our focus remains on integration improvements, raw material savings, SG&A expenses and inventory reductions."